Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Despite the existence of various therapeutic options, NSCLC is still a major health concern due to its aggressive nature and high mutation rate. Consequently, HER3 has been selected as a target protein along with EGFR because...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ayed A. Dera, Sumera Zaib, Areeba, Nadia Hussain, Nehal Rana, Hira Javed, Imtiaz Khan
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2023-06-01
Σειρά:	Molecules
Θέματα:	chemoresistance epidermal growth factor receptor HER3 lung cancer pharmacophore design
Διαθέσιμο Online:	https://www.mdpi.com/1420-3049/28/12/4850
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!